Breast Cancer
Tc-99m-MIBI scan is a prognostic factor in breast cancer
Published in Cancer Weekly, September 16th, 2003
According to recent research from Italy, "Evaluation of treatment response is of primary importance in the management of patients with cancer. Both positron- and gamma-emitting compounds have been used to monitor changes in tumor metabolism or viability after therapy.
"The use of Tc-99m-labeled lipophilic cations raised the possibility to predict the tumor response to treatment and to identify patients who win become refractory to subsequent therapy. In particular, many studies have shown the prognostic value of Tc-99m-MIBI scan in different types of malignancy including breast and lung...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-09-16)
More Articles from Cancer Weekly
- Bladder Cancer
Survival rates jump significantly with presurgery chemotherapy - Oncogenes
Research pinpoints gene that increases cancer risk by 26% - Breast Cancer
Elevated DNA damage is significantly associated with breast cancer risk - Cancer Mortality
Progress shown in death rates from four leading cancers - MALT Lymphoma
Gene crucial for antibody-producing cell development is key to blood cell cancer - Transduction
A new adaptor protein reactivates mutant p53 to cause tumor destruction - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
